Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram

Peter S.N. van Rossum(Amsterdam University Medical Centers), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Max Peters(University Medical Center Utrecht), Radhe Mohan(The University of Texas MD Anderson Cancer Center), David M. Routman(Mayo Clinic in Arizona), Christopher L. Hallemeier(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), Amy Liu(The University of Texas MD Anderson Cancer Center), Xu Cai(Shanghai Medical College of Fudan University), Yutaka Shiraishi(The University of Texas MD Anderson Cancer Center), Wei Deng(Wuhan University)
Practical Radiation Oncology
July 29, 2019
10.1016/j.prro.2019.07.010
Cited by 67

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Integrating genomic features for non-invasive early lung cancer detection
|Nature|2020|689
Neuropeptide S
|Neuron|2004|516
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369